logo
15:55 Feb 13

Lyka Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
69.06
-1.15 (-1.64%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lyka Labs Ltd. Financials

Lyka Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
69.06
-1.15 (-1.64%)
15:55 Feb 13
Quality
image/svg+xml

75/100
High Financial Strength

Valuation
image/svg+xml

18/100
Expensive Valuation

Technical

25/100
Technically Bearish

Strength

10

Weakness

8

Opportunity

0

Threats

0

7.73 %

ROE %

4.54 %

ROA %

-0.18

EPS

29.01

BVPS

5.78 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
86.25 194.08 93.07 111.19 138.5
Operating Expenses +
66.57 92.93 76.23 95.48 120.56
Raw Material
34.91 53.39 38.77 45.63 56.95
Increase Decrease in Cost
3.06 -0.41 -1.21 -0.78 -1.36
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
14.57 18.06 18.61 26.77 34.63
Miscellaneous Expenses
59.23 74.79 51.44 50.84 70.1
Operating Profit
19.68 101.15 16.84 15.71 17.94
Other Income
1.56 2.09 3.4 1.45 2.23
Depreciation
8.32 17.35 14.15 12.8 6.77
Interest
25.94 20.13 11.87 4.89 2.27
Profit before tax and exceptio..
-13.02 65.77 -5.78 -0.52 11.12
Exceptional Items
-1.13 -6.52 -7.39 -0.41 0
PBT
-14.14 59.25 -13.17 -0.93 11.12
Provision for Taxation
-4.05 20.8 -0.02 1.69 3.19
Net Profit
-10.09 38.44 -13.15 -2.62 7.93
NET Profit after MI
-11.55 39 -13.21 -2.49 8.01
EPS
-4.07 13.57 -4.63 -0.79 2.22
Operating Profit Margin (%)
22.82 52.12 18.09 14.13 12.95
Net Profit Margin (%)
-13.39 20.09 -14.19 -2.24 5.78

Lyka Labs Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: